The ISPE 2022 Facilities of the Future Conference Opening Plenary provided views of lessons learned during the pandemic that will help the pharmaceutical industry to accelerate development of new...
The 2023 ISPE Facilities of the Future Conference will explore advancements in pharmaceutical technology and what pharmaceutical manufacturing facilities will look like in the future. Featuring technical and inspirational presentations and case-studies from industry leaders already planning and building “facilities of the future”.
Thank you to the program committee, speakers, exhibitors, sponsors, and attendees for making the 2022 ISPE Facilities of the Future Conference a HUGE success! Watch this clip to hear from ISPE Board Chair Jörg Zimmermann, Vice President, Vetter Development Service, External Affairs, Vetter Pharma, as he highlights one of his favorite sessions from the event.
During the plenary session of the 2022 ISPE Facilities of the Future Conference, Matthew Hepburn, MD, Senior Advisor To the Director, Pandemic Prevention, U.S. Office of Science and Technology Policy, Executive Office of the President, shared lessons learned from Operation Warp Speed.
In this clip, he urges the industry to keep the rapid pace of manufacturing and innovation moving forward—keep making the impossible possible.
Yury Yohana Gomez, Global Strategy Leader, WW Manufacturing & Supply Chain, Microsoft, shares how her company is adopting new technologies due to the pandemic.
mRNA is not just the basis of new COVID-19 vaccines. mRNA is also a versatile technology for the development and manufacturing of new medicinal product candidates such as cancer. Watch this clip from #ISPEFoF to hear from Oliver Hennig, Senior Vice President Operations, BioNTech SE, as he describes the mRNA approach for oncology.
What are the benefits of sustainability in transportable manufacturing? Mark Butler, President and Managing Director, IPS-Integrated Project Services posed this question during the #ISPEFoF session on modular facilities.
Watch this clip to hear from Michael K. O'Brien, PhD, President & CEO, NGT BioPharma Consultants, and Dennis Powers, Vice President of Business Development & Design Consulting, G-CON Manufacturing.